Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Cascone

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Cancers|March 10, 2022
Current Surgical Indications for Non-Small-Cell Lung CancerNathaniel Deboever, Kyle G Mitchell, Hope A Feldman, et al.
Nature Reviews. Clinical Oncology|May 16, 2025
Tumour and microenvironment crosstalk in NSCLC progression and response to therapyZahraa Rahal, Roy El Darzi, Seyed Javad Moghaddam, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 15, 2026
Navigating Multimodality Therapy in Non-Small Cell Lung Cancer: Neoadjuvant-Only Versus Perioperative Immunotherapy, Surgical Imperatives, and Future ApproachesGökce Yavuz, Michael Wang, Jonathan D Spicer, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Epidermal growth factor receptor inhibitors in non-small-cell lung cancerTina Cascone, Erika Martinelli, Maria Pia Morelli, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Targeted therapies for lung cancer: clinical experience and novel agentsJill E Larsen, Tina Cascone, David E Gerber, et al.
Nature Reviews. Clinical Oncology|April 29, 2021
Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancerJamie E Chaft, Andreas Rimner, Walter Weder, et al.
Nature Cancer|June 24, 2025
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer typesGil Awada, Tina Cascone, Michiel S van der Heijden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2022
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer TherapySonia A Patel, Monique B Nilsson, Xiuning Le, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2021
Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatmentAnnikka Weissferdt, Apar Pataer, Stephen G Swisher, et al.
Journal of the National Cancer Institute|November 8, 2022
Disparity in checkpoint inhibitor utilization among commercially insured adult patients with metastatic lung cancerMeng Li, Kaiping Liao, Alice J Chen, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Cancers|March 10, 2022
Current Surgical Indications for Non-Small-Cell Lung CancerNathaniel Deboever, Kyle G Mitchell, Hope A Feldman, et al.
Nature Reviews. Clinical Oncology|May 16, 2025
Tumour and microenvironment crosstalk in NSCLC progression and response to therapyZahraa Rahal, Roy El Darzi, Seyed Javad Moghaddam, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 15, 2026
Navigating Multimodality Therapy in Non-Small Cell Lung Cancer: Neoadjuvant-Only Versus Perioperative Immunotherapy, Surgical Imperatives, and Future ApproachesGökce Yavuz, Michael Wang, Jonathan D Spicer, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Epidermal growth factor receptor inhibitors in non-small-cell lung cancerTina Cascone, Erika Martinelli, Maria Pia Morelli, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Targeted therapies for lung cancer: clinical experience and novel agentsJill E Larsen, Tina Cascone, David E Gerber, et al.
Nature Reviews. Clinical Oncology|April 29, 2021
Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancerJamie E Chaft, Andreas Rimner, Walter Weder, et al.
Nature Cancer|June 24, 2025
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer typesGil Awada, Tina Cascone, Michiel S van der Heijden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2022
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer TherapySonia A Patel, Monique B Nilsson, Xiuning Le, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2021
Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatmentAnnikka Weissferdt, Apar Pataer, Stephen G Swisher, et al.
Journal of the National Cancer Institute|November 8, 2022
Disparity in checkpoint inhibitor utilization among commercially insured adult patients with metastatic lung cancerMeng Li, Kaiping Liao, Alice J Chen, et al.
Pageof 13